Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Garcia-Prats

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|June 23, 2015
Antituberculosis drugs in childrenH S Schaaf, A J Garcia-Prats, P R Donald
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2015
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerationsR Taneja, A J Garcia-Prats, J Furin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trialsS Kim, J A Seddon, A J Garcia-Prats, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 10, 2014
Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigationA J Garcia-Prats, K Zimri, Z Mramba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in childrenH S Schaaf, A J Garcia-Prats, K du Preez, et al.
Tuberculosis (Edinburgh, Scotland)|March 24, 2015
Fluoroquinolones for the treatment of tuberculosis in childrenS Thee, A J Garcia-Prats, P R Donald, et al.
Tuberculosis (Edinburgh, Scotland)|November 21, 2015
A review of the use of ethionamide and prothionamide in childhood tuberculosisS Thee, A J Garcia-Prats, P R Donald, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in childrenA J Garcia-Prats, E M Svensson, E D Weld, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done?J A Seddon, E D Weld, H S Schaaf, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2020
A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South AfricaK Zimri, R Casper, G Hoddinott, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|June 23, 2015
Antituberculosis drugs in childrenH S Schaaf, A J Garcia-Prats, P R Donald
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2015
Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerationsR Taneja, A J Garcia-Prats, J Furin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trialsS Kim, J A Seddon, A J Garcia-Prats, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 10, 2014
Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigationA J Garcia-Prats, K Zimri, Z Mramba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in childrenH S Schaaf, A J Garcia-Prats, K du Preez, et al.
Tuberculosis (Edinburgh, Scotland)|March 24, 2015
Fluoroquinolones for the treatment of tuberculosis in childrenS Thee, A J Garcia-Prats, P R Donald, et al.
Tuberculosis (Edinburgh, Scotland)|November 21, 2015
A review of the use of ethionamide and prothionamide in childhood tuberculosisS Thee, A J Garcia-Prats, P R Donald, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in childrenA J Garcia-Prats, E M Svensson, E D Weld, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Conducting efficacy trials in children with MDR-TB: what is the rationale and how should they be done?J A Seddon, E D Weld, H S Schaaf, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2020
A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South AfricaK Zimri, R Casper, G Hoddinott, et al.
Pageof 3